Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Gabriel A. Robbins"'
Autor:
Mark J. Mulligan, Gabriel A. Robbins, Ellie Carmody, Jaishvi Eapen, Yi Li, Alexander Hrycko, Vanessa Raabe, Brooklyn Henderson, Dinuli Delpachitra, Yanina Dubrovskaya, Jonathan S. Austrian, Morris Jrada, Martin Backer, Prithiv J. Prasad, Jack DeHovitz, Camila Delgado, Andrea B. Troxel, Robert J. Ulrich
Publikováno v:
Open Forum Infectious Diseases
Background Effective therapies to combat coronavirus 2019 (COVID-19) are urgently needed. Hydroxychloroquine (HCQ) has in vitro antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but the clinical benefit of HCQ i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2f9c302bc2e4a1e14b8353608a04ce8
http://europepmc.org/articles/PMC7543602
http://europepmc.org/articles/PMC7543602
Autor:
William L. Carroll, Gabriel A. Robbins, Cynthia Loomis, Yuling Dai, Iannis Aifantis, Kathryn G. Roberts, Anastasia N. Tikhonova, Chao Ma, Chunxu Qu, Igor Dolgalev, Nikki A. Evensen, Deqing Pei, Aristotelis Tsirigos, Cheng Cheng, Michael E. Scheurer, Shanmugapriya Selvaraj, Karen R. Rabin, Marla Daves, Audrey Lasry, Charles G. Mullighan, Sheetal Sreeram, Valeria Mezzano, Joanna Pierro, Tiffany Chambers, Weiqiang Chen, Philip J. Lupo, Matthew T. Witkowski
Publikováno v:
Cancer Cell
Summary A subset of B cell acute lymphoblastic leukemia (B-ALL) patients will relapse and succumb to therapy-resistant disease. The bone marrow microenvironment may support B-ALL progression and treatment evasion. Utilizing single-cell approaches, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89797ea734523a2caae12da541fe7692
https://doi.org/10.1016/j.ccell.2020.04.015
https://doi.org/10.1016/j.ccell.2020.04.015